Ofrecer información sobre las oportunidades de financiación disponibles para potenciar el crecimiento y desarrollo de proyectos empresariales de I+D+i es el objetivo de la jornada que ha organizado ...
Read moreIt has been demonstrated in animal models the benefits of vorinostat after having suffered a stroke. The drug, used in humans to treat cutaneous T-cell lymphoma, has been proved to mitigate brain inju...
Read moreThe DEFINITIVE project, led by IDIBAPS, will be conducted across 44 hospitals in a total of 7 European and associated countries to demonstrate that use of genomic test HER2DX® improves quality of lif...
Read moreIn this context, the doctoral thesis of the Lorena Joga, child and youth neuropsychologist at Parc Taulí and member of the I3PT Growth and Developmental Disorders Research Group, with the title "Frag...
Read moreThe study analyzes data from women with pathogenic variants of the BRCA1 or BRCA2 genes and shows that those with BRCA1 sequence variations undergoing magnetic resonance imaging follow-up have a signi...
Read moreEl Hospital Universitario Miguel Servet de Zaragoza ha realizado el primer implante de riñón en una persona a partir de un injerto mantenido en unas condiciones óptimas, muy superiores a los están...
Read moreDescriben las principales diferencias morfológicas existentes en las estructuras internas de los colmillos de hombres y mujeres de poblaciones actuales y destaca la utilidad de esta pieza dental para...
Read moreThe Nucleic Acids Chemistry group, led by Prof. Ramon Eritja’s of the IQAC (CSIC), is participating in a multidisciplinary network for Myotonic Dystrophy Type 1 (DM1) with other 6 research groups...
Read more¿Cómo puedo prevenir/evitar el estreñimiento? El estreñimiento consiste en la situación en que una persona presenta menos de tres deposiciones a la semana, con heces duras y secas, de evacuació...
Read moreIn an international study, they propose optimizing the design of clinical trials in rare tumors to speed up the study and approval of new drugs that will make it possible to respond to patients with t...
Read moreIn the fight against these diseases, at IRB Barcelona, they are committed to interdisciplinary research through new projects aimed at better understanding rare diseases and developing new therapies an...
Read moreApproximately 80% of RRDs are genetic in origin, while the remaining 20% are the result of infectious, immunological, degenerative or proliferative diseases. The most important problem faced by patien...
Read more